SANOFI80 logo

Sanofi SET:SANOFI80 Stock Report

Last Price

฿3.68

Market Cap

฿4.6t

7D

1.7%

1Y

n/a

Updated

16 Feb, 2025

Data

Company Financials +

SANOFI80 Stock Overview

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. More details

SANOFI80 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance4/6
Financial Health6/6
Dividends5/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Sanofi Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sanofi
Historical stock prices
Current Share Price€3.68
52 Week High€3.76
52 Week Low€3.16
Beta0.46
1 Month Change3.37%
3 Month Change8.24%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO1.10%

Recent News & Updates

Recent updates

Shareholder Returns

SANOFI80TH PharmaceuticalsTH Market
7D1.7%-1.9%-0.8%
1Yn/a3.3%-8.9%

Return vs Industry: Insufficient data to determine how SANOFI80 performed against the TH Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how SANOFI80 performed against the TH Market.

Price Volatility

Is SANOFI80's price volatile compared to industry and market?
SANOFI80 volatility
SANOFI80 Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement4.7%
10% most volatile stocks in TH Market9.5%
10% least volatile stocks in TH Market2.1%

Stable Share Price: SANOFI80 has not had significant price volatility in the past 3 months compared to the TH market.

Volatility Over Time: Insufficient data to determine SANOFI80's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199482,878Paul Hudsonwww.sanofi.com

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
SANOFI80 fundamental statistics
Market cap฿4.60t
Earnings (TTM)฿194.67b
Revenue (TTM)฿1.57t

23.7x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SANOFI80 income statement (TTM)
Revenue€44.29b
Cost of Revenue€13.20b
Gross Profit€31.09b
Other Expenses€25.60b
Earnings€5.50b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Apr 24, 2025

Earnings per share (EPS)4.38
Gross Margin70.21%
Net Profit Margin12.41%
Debt/Equity Ratio20.6%

How did SANOFI80 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

89%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 15:34
End of Day Share Price 2025/02/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sanofi is covered by 60 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
John EadeArgus Research Company
Odile RundquistBaader Helvea Equity Research